This review comprehensively describes recent advances in the management of malignant
central airway obstruction (CAO). Malignant CAO can be a dramatic and devastating …

Interventional pulmonary medicine has developed as a subspecialty focused on the
management of patients with complex thoracic disease. Leveraging minimally invasive …

Introduction Central airway obstruction (CAO) is a life-threatening complication of lung
cancer. The prevalence of CAO in lung cancer patients is unknown. We audited CAO burden …

Background: The prevalence of malignant central airway obstruction at diagnosis and its 5-
year incidence are largely unknown, as are basic epidemiological data pertaining to this …

Background Malignant central airway obstruction (CAO) occurs in approximately 20–30% of
patients with lung cancer and is associated with debilitating symptoms and poor prognosis …

Malignant central airway obstruction (MCAO) is a debilitating and life-limiting complication
that occurs in an unfortunately large number of individuals with advanced intrathoracic …

Malignant central airway obstruction (MCAO) impacts many patients with advanced primary
lung cancers and metastatic disease to the thorax and may cause substantial symptoms and …

Simple Summary Malignant Central Airway Obstruction (MCAO) is a serious complication of
lung cancer, leading to increased morbidity and mortality. MCAO can present in three major …

Background Central airway obstruction (CAO), seen in a variety of malignant and non-
malignant airway disorders, is associated with a poor prognosis. The management of CAO is …

Stenosis reduces the effective lumen area in the tracheal and bronchial segments of the
airway anatomy. Loss in patency due to obstruction increases resistance to airflow; thus …